GENUS PLC UNSP/ADR (GENSY) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 14 55 sessions, October 16, 2025 to July 7, 2026
- Largest daily move
- -11.7% close of November 26, 2025
Company Description
GENUS PLC UNSP/ADR (OTC: GENSY) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $2.3B.
GENSY has declined 24.9% so far this year. The last closing price was $28.38.
This page collects what Stock Titan holds for GENSY, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
GENUS PLC UNSP/ADR (GENSY) closed at $28.38 on July 7, 2026. So far this year, the price has lost 24.9%.
GENSY Metrics & Rankings
Price returns through July 7, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
GENUS PLC UNSP/ADR has 5 recent news articles. Key topics include acquisition, AI. View all GENSY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in GENUS PLC UNSP/ADR (GENSY) currently stands at 9 shares. Since September 2025, short interest has decreased by 91.0%.
Days to Cover History
Days to cover for GENUS PLC UNSP/ADR (GENSY) currently stands at 1.3 days, up 29% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 99.9% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
GENSY Company Profile & Sector Positioning
GENUS PLC UNSP/ADR (GENSY) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing GENSY often look at related companies in the same sector, including NORTHWEST BIOTHRPUTCS INC (NWBO), CYTODYN INC (CYDY), CLINUVEL PHARMS LTD S/ADR (CLVLY), NUO THERAPEUTICS INC NEW (AURX), and ALK-ABELLO AS B SHS NEW (AKBLF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GENSY's relative position within its industry.